All Pharma articles – Page 5
-
CommentThe forgotten staffing shortages in primary care
Malcolm Harrison writes about the main reasons for the growing shortage of community pharmacists and gives his take on how to avert the deepening crisis
-
NewsHealth leaders hit out at firms for continuing Russia links
Simon Stevens and Jeremy Hunt have hit out at companies with NHS links which continue to trade with Russia.
-
HSJ PartnersConnected medication management – How can BD help make it a reality?
Medication errors harm patients and cost the NHS money – but with the right approach they can be significantly reduced. A 2018 study from researchers at York, Manchester and Sheffield universities found that there were likely to be 237 million medication errors a year in the NHS and this could ...
-
CommentThe secret weapon that could help win the PM’s war on cancer
Andrew M Wardley says there is one intervention that can both help catch cancer earlier and reduce health inequalities in cancer care: expanding outreach cancer services
-
HSJ PartnersMore than skin deep – understanding the burden of psoriasis and psoriatic arthritis (PsA)
Focusing on psoriasis could help to manage costly comorbidities, policymakers told
-
HSJ PartnersTackling covid-related challenges in services for patients with respiratory conditions
The covid pandemic has created challenges for many NHS services, including those dealing with patients with respiratory conditions. Sponsored by A webinar, sponsored by Boehringer Ingelheim, at HSJ’s virtual respiratory forum looked at the impact on services for patients with idiopathic pulmonary fibrosis and how these could be ...
-
NewsTechnology ‘tsunami’ creates funding challenge, says regulator chief
The ‘tsunami’ of digital health technologies being adopted by the NHS is putting a strain on regulators’ ability to determine which ones offer value for money, according to outgoing National Institute for Health and Care Excellence chief executive Gill Leng.
-
NewsInsurance boss named NICE chief executive
Samantha Roberts, the managing director of insurance provider Legal and General’s health and care business, is to become the chief executive of the National Institute for Health and Care Excellence.
-
HSJ PartnersClinical spotlight – What do emerging treatments for cancer tell us about how the NHS can best adopt and spread innovation?
This is paid-for content from our commercial partners. Find out more This article was organised and fully funded by Bristol Myers Squibb, as a follow-up to a roundtable hosted in collaboration with HSJ. Bristol Myers Squibb has not determined the content of the ...
-
HSJ InteractiveHow can we improve medication safety?
An HSJ roundtable, in association with BD, looked at what has been done to reduce risk of harm from medicines, and what the next steps of progress could be
-
NewsHealth secretary to act on racial bias in effectiveness of medical devices
Sajid Javid has said medical device manufacturers should check their products work well for people of all ethnic backgrounds, citing problems that those with dark skin have experienced when using pulse oximeters.
-
HSJ AwardsHSJ Patient Safety Awards 2021:Improving Safety in Medicines Management Award
Partnered by WINNER: Royal Surrey FT: St Luke’s Cancer Centre and Pharmacy Team Delivery of Safe Systemic Anti-Cancer Treatment During the Covid-19 Pandemic
-
HSJ PartnersClinical engagement in service development holds the key to embedding innovation in cancer services
This is paid-for content from our commercial partners. Find out more This article was organised and fully funded by Bristol Myers Squibb, and developed in collaboration by BMS and HSJ. This article has no promotional intent. Bristol-Myers Squibb does not intend to encourage the use ...
-
HSJ AwardsHSJ Value Awards 2021: Pharmacy and Medicines Optimisation Award
WINNER: Northern Devon Healthcare Trust: Medicines Optimisation in Orthopaedic Enhanced Recovery The pharmacy department of a district general hospital worked with the multidisciplinary team in orthopaedics to reduce variation in medication use among elective hip and knee replacement patients. The project focused on the following points to optimise medication use: ...
-
NewsInterim chief commercial officer chosen by NHS England
The NHS’ ‘chief negotiator with the pharmaceutical industry’ has been made interim chief commercial officer after the incumbent CCO left to head up Downing Street’s new delivery unit.
-
NewsGroup set up by govt review flags ‘culture of protect and deny’
A “systemic culture of protect and deny” in government means many more women and children will be harmed through poor care, according to the co-chair of an official patient group set up to review medical devices.
-
NewsNHSE confirms consultation on mandatory staff covid vaccination
The number of pharmacies delivering the covid-19 vaccination is set to more than double for the planned autumn booster campaign, new guidance states.
-
HSJ LocalCritical report on leading trust watered down ‘on an industrial scale’
Findings included in a draft report which were strongly critical of a prominent cancer trust were extensively deleted or softened before publication, HSJ has discovered.
-
CommentNew regulation will balance safety and innovation
If the UK is to maintain its position as a champion of life sciences, its new regulatory regime must find the middle ground between safety and innovation, notes Lord Ara Darzi
-
Expert BriefingNorth by North West: The tough questions NHSE must answer over famous cancer trust
Essential insight into NHS matters in the North West of England. Contact me in confidence here.